Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study-Reference-Cited by-同舟云学术

Age‐specific effectiveness of primary human papillomavirus screening versus cytology in a cervical cancer screening program: a nationwide cross‐sectional study

Published:2022-02-10 Issue:3 Volume:42 Page:191-204
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Bao Heling¹,Ma Lan²,Zhao Yanxia²,Song Bo²,Di Jiangli²,Wang Linhong³,Gao Yanqiu¹,Ren Wenhui²,Wang Shi¹,Wu Jiuling²,Wang Hai‐Jun¹

Affiliation:

1. Department of Maternal and Child Health, School of Public Health Peking University Beijing 100191 P. R. China

2. National Center for Women and Children's Health Chinese Center for Disease Control and Prevention Beijing 100081 P. R. China

3. National Center for Chronic and Non‐communicable Disease Control and Prevention Chinese Center for Disease Control and Prevention Beijing 100050 P. R. China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12256

Reference32 articles.

1. WHO.WHO Director‐General calls for all countries to take action to help end the suffering caused by cervical cancer. 2018 [cited 2019 Sep 10]. Available from:https://www.who.int/reproductivehealth/call‐to‐action‐elimination‐cervical‐cancer/en/.

2. WHO.WHO guideline for screening and treatment of cervical pre‐cancer lesions for cervical cancer prevention second edition. 2021 [cited 2021 July 10]. Available from:https://www.who.int/publications‐detail‐redirect/9789240030824.

3. Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials

4. Screening for Cervical Cancer With High-Risk Human Papillomavirus Testing

5. Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Age-specific performance of human papillomavirus E6/E7 mRNA assay versus cytology for primary cervical cancer screening and triage: community-based screening in China;Frontiers in Cellular and Infection Microbiology;2024-08-29

2. Prevalence and genotype distribution of HPV combined with cervical pathological results in women from Sichuan, China: A cross‐sectional study based on post‐vaccination period 2019 to 2023;Cancer Medicine;2024-08

3. The prevalence and genotype distribution of human papillomavirus in central Fujian Province during the COVID-19 pandemic;Virology Journal;2024-06-05

4. Discussion on cervical cytology in postmenopausal women;Minerva Obstetrics and Gynecology;2023-10

5. Evaluation of HPV infection helps to direct ALA-PDT of condyloma acuminata;Photodiagnosis and Photodynamic Therapy;2023-09